These findings were corroborated by a meta-analysis of multiple nano-curcumin RCTs, which showed consistent improvements in FBG, fasting insulin, insulin resistance (HOMA-IR), lipid metabolism, and inflammatory biomarkers [154,155,156]. The gene discussed is INS; the disease is Insulin resistance.